[ORGANIZATION]
Crossmark Global Holdings Inc.
Featured in 1 tracked story · first seen
Situations
Iovance Biotherapeutics financial performance and stock rise
2 clusters · 4 sources · last updated
Latest: Iovance Biotherapeutics surges as institutional investors shift Qualcomm and Atkore holdings
Iovance Biotherapeutics experienced significant financial growth and stock market momentum in mid-2026. The company reported second-quarter revenue of approximately $99.3 million, representing a 66% increase from the pre